Abingworth related stories
All articles and analysis
First institutional cleantech fund holds close on €50mEnvironmental Technologies Fund is blazing a green trail with its debut cleantech fund offering for institutional investors.
- Rowlands emerges as UK growth tsar
The former head of 3i Asia will preside over a review of SME funding in the UK and decide whether a state-backed equity investor will be needed to boost the economy. 3i was founded in 1945 under similar circumstances.
- Environmental Technologies Fund closes £110m fund
The first-time venture fund is backed by financial institutions aiming to capitalise on the numerous possibilities for green technologies in Europe.
- Global firms dominate the PEI Awards
In spite of the credit crunch, the global mega funds took centre stage in the Private Equity International Awards 2007. Mid-market resilience also found favour with voters in the only truly democratic private equity awards.
- Evans is ’shocked and dismayed’
One of the grandees of the UK venture capital scene has given his reaction to his arrest and implication in the cash-for-honours inquiry plaguing some high-profile lenders to the UK Labour Party.
- SV Life Sciences closes fourth fund on $572m(2)
SV Life Sciences has closed its fourth fund on $572m, just under the £300m fund that Abingworth closed last month but far exceeding its original target of $400m.
- Abingworth closes record life sciences fund at £300 million
Abingworth has closed a record £300 million fund, which will target life sciences investments in Europe and North America.
- SV Life Sciences closes fourth fund on $572m
SV Life Sciences has closed its fourth fund on $572m, just under the £300m fund that Abingworth closed last month but far exceeding its original target of $400m.
- Abingworth hires recruitment pro
In its fourth appointment in two months, Abingworth Management has recruited Sarah Shackleton to develop industry relationships and help portfolio companies recruit managers.
- Abingworth appoints biotech manager
Abingworth Management, the venture capital firm specialising in life science, has appointed Joe Anderson as manager of its investments in quoted development-stage biotech firms.